Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>

Common stock purchase or sale:
Transaction Date |
Reported DateTime |
Company | Symbol | Insider Relationship |
Shares Traded |
Average Price |
Total Amount |
Shares Owned |
Filing |
2023-06-05 Sale |
2023-06-07 4:30 pm |
Editas Medicine Inc. | EDIT | Eaton Bruce EVP, CBO AND CTO |
105 | $9.503 | $998 | 76,674 (Direct) |
View |
2023-05-11 Sale |
2023-05-15 4:30 pm |
Editas Medicine Inc. | EDIT | ROBERTSON MICHELLE EVP, CHIEF FINANCIAL OFFICER |
949 | $9.872 | $9,369 | 106,610 (Direct) |
View |
2023-05-11 Sale |
2023-05-15 4:30 pm |
Editas Medicine Inc. | EDIT | Eaton Bruce EVP, CBO AND CTO |
668 | $9.872 | $6,594 | 76,779 (Direct) |
View |
2023-05-09 Sale |
2023-05-11 4:30 pm |
Editas Medicine Inc. | EDIT | Eaton Bruce EVP, CBO AND CTO |
135 | $9.51 | $1,284 | 77,447 (Direct) |
View |
2023-03-03 Sale |
2023-03-06 4:30 pm |
Editas Medicine Inc. | EDIT | ROBERTSON MICHELLE EVP, CHIEF FINANCIAL OFFICER |
184 | $8.89 | $1,636 | 202,059 (Direct) |
View |
2023-03-03 Sale |
2023-03-06 4:30 pm |
Editas Medicine Inc. | EDIT | Eaton Bruce EVP, CBO AND CTO |
101 | $8.89 | $898 | 127,582 (Direct) |
View |
2023-02-13 Sale |
2023-02-15 4:30 pm |
Editas Medicine Inc. | EDIT | Shearman Mark S EVP, CHIEF SCIENTIFIC OFFICER |
2,790 | $9.6653 | $26,966 | 65,559 (Direct) |
View |
2023-02-13 Sale |
2023-02-15 4:30 pm |
Editas Medicine Inc. | EDIT | ROBERTSON MICHELLE EVP, CHIEF FINANCIAL OFFICER |
4,287 | $9.6653 | $41,435 | 76,243 (Direct) |
View |
2023-02-13 Sale |
2023-02-15 4:30 pm |
Editas Medicine Inc. | EDIT | Eaton Bruce EVP, CBO AND CTO |
3,307 | $9.6653 | $31,963 | 60,983 (Direct) |
View |
2023-02-07 Sale |
2023-02-09 4:30 pm |
Editas Medicine Inc. | EDIT | Eaton Bruce EVP, CBO AND CTO |
346 | $11.1 | $3,841 | 64,290 (Direct) |
View |
2023-01-10 Sale |
2023-01-12 4:30 pm |
Editas Medicine Inc. | EDIT | ROBERTSON MICHELLE EVP, CHIEF FINANCIAL OFFICER |
1,752 | $8.1601 | $14,296 | 80,530 (Direct) |
View |
2022-12-05 Sale |
2022-12-06 4:30 pm |
Editas Medicine Inc. | EDIT | ROBERTSON MICHELLE EVP, CHIEF FINANCIAL OFFICER |
193 | $10.23 | $1,974 | 82,282 (Direct) |
View |
2022-12-05 Sale |
2022-12-06 4:30 pm |
Editas Medicine Inc. | EDIT | Eaton Bruce EVP, CHIEF BUSINESS OFFICER |
102 | $10.23 | $1,043 | 64,636 (Direct) |
View |
2022-11-08 Sale |
2022-11-09 4:30 pm |
Editas Medicine Inc. | EDIT | Eaton Bruce EVP, CHIEF BUSINESS OFFICER |
289 | $11.02 | $3,185 | 64,738 (Direct) |
View |
2022-09-06 Sale |
2022-09-08 4:30 pm |
Editas Medicine Inc. | EDIT | ROBERTSON MICHELLE EVP, CHIEF FINANCIAL OFFICER |
192 | $15.01 | $2,882 | 82,475 (Direct) |
View |
2022-09-06 Sale |
2022-09-08 4:30 pm |
Editas Medicine Inc. | EDIT | Eaton Bruce EVP, CHIEF BUSINESS OFFICER |
101 | $15.01 | $1,516 | 65,027 (Direct) |
View |
2022-08-09 Sale |
2022-08-10 4:30 pm |
Editas Medicine Inc. | EDIT | Eaton Bruce EVP, CHIEF BUSINESS OFFICER |
293 | $18.6 | $5,449 | 65,128 (Direct) |
View |
2022-06-15 Sale |
2022-06-16 4:15 pm |
Editas Medicine Inc. | EDIT | Shearman Mark S EVP, CHIEF SCIENTIFIC OFFICER |
5,145 | $10.06 | $51,745 | 68,349 (Direct) |
View |
Stock options: Exercise, Award, Grant, Conversion
Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
2023-06-01 Option Award |
2023-06-05 4:30 pm |
N/A 2033-05-31 |
Editas Medicine Inc. | EDIT | Hopfield Jessica Director |
25,000 | $0 | 25,000 (Direct) |
View |
2023-06-01 Option Award |
2023-06-05 4:30 pm |
N/A 2033-05-31 |
Editas Medicine Inc. | EDIT | Connaughton Bernadette Director |
25,000 | $0 | 25,000 (Direct) |
View |
2023-06-01 Option Award |
2023-06-05 4:30 pm |
N/A 2033-05-31 |
Editas Medicine Inc. | EDIT | Reeve Emma Director |
25,000 | $0 | 25,000 (Direct) |
View |
2023-06-01 Option Award |
2023-06-05 4:30 pm |
N/A 2033-05-31 |
Editas Medicine Inc. | EDIT | Vaishnaw Akshay Director |
25,000 | $0 | 25,000 (Direct) |
View |
2023-06-01 Option Award |
2023-06-05 4:30 pm |
N/A 2033-05-31 |
Editas Medicine Inc. | EDIT | Hirsch Andrew Director |
25,000 | $0 | 25,000 (Direct) |
View |
2023-06-01 Option Award |
2023-06-05 4:30 pm |
N/A 2033-05-31 |
Editas Medicine Inc. | EDIT | Scadden David Director |
25,000 | $0 | 25,000 (Direct) |
View |
2023-06-01 Option Award |
2023-06-05 4:30 pm |
N/A 2033-05-31 |
Editas Medicine Inc. | EDIT | Chatterjee Meeta Director |
25,000 | $0 | 25,000 (Direct) |
View |
2023-05-17 Option Award |
2023-05-18 5:20 pm |
N/A 2033-05-16 |
Editas Medicine Inc. | EDIT | Lucera Erick EVP, CHIEF FINANCIAL OFFICER |
233,700 | $0 | 233,700 (Direct) |
View |
2023-04-11 Option Award |
2023-04-13 4:53 pm |
N/A 2033-04-10 |
Editas Medicine Inc. | EDIT | Levy Elliott M. Director |
50,000 | $0 | 50,000 (Direct) |
View |
2023-03-02 Option Award |
2023-03-06 4:30 pm |
N/A 2033-03-01 |
Editas Medicine Inc. | EDIT | ROBERTSON MICHELLE EVP, CHIEF FINANCIAL OFFICER |
126,000 | $0 | 202,059 (Direct) |
View |
2023-03-02 Option Award |
2023-03-06 4:30 pm |
N/A 2033-03-01 |
Editas Medicine Inc. | EDIT | Mei Baisong SVP, CHIEF MEDICAL OFFICER |
72,000 | $0 | 130,372 (Direct) |
View |
2023-03-02 Option Award |
2023-03-06 4:30 pm |
N/A 2033-03-01 |
Editas Medicine Inc. | EDIT | O'Neill Gilmore Neil CEO |
200,000 | $0 | 286,655 (Direct) |
View |
2023-03-02 Option Award |
2023-03-06 4:30 pm |
N/A 2033-03-01 |
Editas Medicine Inc. | EDIT | Eaton Bruce EVP, CBO AND CTO |
66,700 | $0 | 127,582 (Direct) |
View |
2022-07-18 Option Award |
2022-07-20 4:36 pm |
N/A 2032-07-17 |
Editas Medicine Inc. | EDIT | Mei Baisong SVP, CHIEF MEDICAL OFFICER |
229,974 | $0 | 229,974 (Direct) |
View |
2022-06-09 Option Award |
2022-06-13 4:30 pm |
N/A 2032-06-08 |
Editas Medicine Inc. | EDIT | Connaughton Bernadette Director |
25,000 | $0 | 25,000 (Direct) |
View |
2022-06-09 Option Award |
2022-06-13 4:30 pm |
N/A 2032-06-08 |
Editas Medicine Inc. | EDIT | Vaishnaw Akshay Director |
25,000 | $0 | 25,000 (Direct) |
View |
2022-06-09 Option Award |
2022-06-13 4:30 pm |
N/A 2032-06-08 |
Editas Medicine Inc. | EDIT | Reeve Emma Director |
25,000 | $0 | 25,000 (Direct) |
View |
2022-06-09 Option Award |
2022-06-13 4:30 pm |
N/A 2032-06-08 |
Editas Medicine Inc. | EDIT | Scadden David Director |
25,000 | $0 | 25,000 (Direct) |
View |
2022-06-09 Option Award |
2022-06-13 4:30 pm |
N/A 2032-06-08 |
Editas Medicine Inc. | EDIT | Hopfield Jessica Director |
25,000 | $0 | 25,000 (Direct) |
View |
2022-06-09 Option Award |
2022-06-13 4:30 pm |
N/A 2032-06-08 |
Editas Medicine Inc. | EDIT | Chatterjee Meeta Director |
25,000 | $0 | 25,000 (Direct) |
View |
2022-06-09 Option Award |
2022-06-13 4:30 pm |
N/A 2032-06-08 |
Editas Medicine Inc. | EDIT | Hirsch Andrew Director |
25,000 | $0 | 25,000 (Direct) |
View |